# Insulet Corporation clinical trials: 23 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 23 trials with Insulet Corporation as lead sponsor, 5 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Insulet Corporation: 23 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/insulet-corporation

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 5
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 18, 2026 | NCT07593625 | Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D | Insulet Corporation | Not applicable | Recruiting | Type 1 Diabetes, Type 1 Diabetes Mellitus, Diabetes (DM) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07593625) |
| May 12, 2026 | NCT07579702 | Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System | Insulet Corporation | Not applicable | Recruiting | Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07579702) |
| April 13, 2026 | NCT07521475 | Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes | Insulet Corporation | Not applicable | Recruiting | Type 2 Diabetes Mellitus | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07521475) |
| January 5, 2026 | NCT07317102 | Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B) | Insulet Corporation | Observational | Recruiting | Diabetes, Type 1 Diabetes, Diabetes Mellitus | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07317102) |
| December 11, 2025 | NCT07276776 | An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes | Insulet Corporation | Not applicable | Completed | Type 2 Diabetes Mellitus | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07276776) |
| July 17, 2025 | NCT07070830 | Simplified Onboarding in Adults With Type 2 Diabetes | Insulet Corporation | Not applicable | Completed | Type 2 Diabetes Mellitus | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07070830) |
| June 26, 2025 | NCT07039981 | Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 Diabetes | Insulet Corporation | Not applicable | Completed | Diabetes Mellitus | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07039981) |
| June 26, 2025 | NCT07039942 | French Prospective Multicentric Study in Real World | Insulet Corporation | Observational | Active not recruiting | Diabetes, Diabetes Mellitus, Type 1 Diabetes | 304 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07039942) |
| March 10, 2025 | NCT06865989 | Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes | Insulet Corporation | Not applicable | Completed | Diabetes Mellitus, Type 1, Type 2 | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06865989) |
| August 9, 2024 | NCT06547918 | SmartAdjust 2.0 System With Type 1 and Type 2 Diabetes | Insulet Corporation | Not applicable | Completed | Diabetes Mellitus | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06547918) |
| December 26, 2023 | NCT06181721 | Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes | Insulet Corporation | Not applicable | Completed | Diabetes Mellitus | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06181721) |
| November 22, 2023 | NCT06144554 | Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes | Insulet Corporation | Observational | Recruiting | Type 1 Diabetes | 2,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06144554) |
| June 28, 2023 | NCT05923827 | Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults | Insulet Corporation | Not applicable | Completed | Diabetes Mellitus, Type 1 | 189 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05923827) |
| April 18, 2023 | NCT05815342 | OP5-005 Using Omnipod 5 in Adults With Type 2 | Insulet Corporation | Not applicable | Completed | Type2 Diabetes | 343 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05815342) |
| June 8, 2022 | NCT05409131 | Omnipod 5 System Compared to Pump Therapy | Insulet Corporation | Not applicable | Completed | Type 1 Diabetes | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05409131) |
| November 5, 2020 | NCT04617795 | Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes | Insulet Corporation | Not applicable | Completed | Type 2 Diabetes Mellitus | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04617795) |
| July 20, 2020 | NCT04476472 | Omnipod Horizon™ Automated Glucose Control System Preschool Cohort | Insulet Corporation | Not applicable | Completed | Type 1 Diabetes Mellitus | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04476472) |
| March 24, 2020 | NCT04320069 | Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study | Insulet Corporation | Not applicable | Completed | Type 1 Diabetes | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04320069) |
| December 12, 2019 | NCT04196140 | Pivotal Omnipod Horizon™ Automated Glucose Control System | Insulet Corporation | Not applicable | Completed | Type 1 Diabetes Mellitus | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04196140) |
| November 25, 2019 | NCT04176731 | Prepivotal Omnipod Horizon™ Automated Glucose Control System | Insulet Corporation | Not applicable | Completed | Type 1 Diabetes Mellitus | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04176731) |
| July 13, 2017 | NCT03216460 | Insulet Artificial Pancreas Free-Living IDE3 | Insulet Corporation | Not applicable | Completed | Type1 Diabetes Mellitus | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03216460) |
| February 27, 2017 | NCT03064906 | Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2) | Insulet Corporation | Not applicable | Completed | Type 1 Diabetes Mellitus | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03064906) |
| September 13, 2016 | NCT02897557 | Insulet Artificial Pancreas Early Feasibility Study | Insulet Corporation | Not applicable | Completed | Type 1 Diabetes | 59 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02897557) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 20 |
| Observational | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 17 |
| Recruiting | 5 |
| Active not recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus, Type 1 | 14 |
| Diabetes Mellitus | 7 |
| Diabetes Mellitus, Type 2 | 5 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Air duct cleaning companies in the United States](https://specstream.ai/data/businesses/air-duct-cleaning-companies/united-states)
- [B2B domestic trade companies in the United States](https://specstream.ai/data/businesses/b2b-domestic-trade-companies/united-states)
- [Beauty product suppliers in the United States](https://specstream.ai/data/businesses/beauty-product-suppliers/united-states)
- [Cardiothoracic surgery practices in the United States](https://specstream.ai/data/businesses/cardiothoracic-surgery-practices/united-states)
- [Concierge medicine practices in the United States](https://specstream.ai/data/businesses/concierge-medicine-practices/united-states)
- [Doner kebab restaurants in the United States](https://specstream.ai/data/businesses/doner-kebab-restaurants/united-states)
